Table 2.

AUCs of the ACLF-JM and MELD-Na.

Mortality prediction AUC of the ACLF-JM vs. the MELD-Na in patients with and without ACLF, at baseline and during follow-up
	ACLF				No ACLF
28-day mortality	ACLF-JM	95% CI	MELD-Na	95% CI	ACLF-JM	95% CI	MELD-Na	95% CI
Baseline	0.871	0.844-0.898	0.788	0.754-0.822	0.774	0.717-0.831	0.706	0.643-0.769
48 hours	0.871	0.844-0.898	0.786	0.752-0.820	0.794	0.741-0.847	0.728	0.668-0.788
7 days	0.862	0.833-0.890	0.753	0.716-0.789	0.810	0.761-0.859	0.740	0.684-0.796
14 days	0.840	0.803-0.878	0.731	0.685-0.777	0.833	0.788-0.879	0.748	0.694-0.802
	ACLF				No ACLF
90-day mortality	ACLF-JM	95% CI	MELD-Na	95% CI	ACLF-JM	95% CI	MELD-Na	95% CI
Baseline	0.875	0.840-0.909	0.780	0.737-0.823	0.836	0.807-0.865	0.734	0.700-0.768
48 hours	0.870	0.837-0.903	0.777	0.735-0.818	0.838	0.810-0.867	0.736	0.703-0.770
7 days	0.861	0.832-0.891	0.755	0.717-0.792	0.835	0.806-0.864	0.722	0.687-0.757
14 days	0.833	0.799-0.868	0.719	0.677-0.761	0.837	0.809-0.865	0.717	0.682-0.752

All AUCs differed significantly (p <0.001)

ACLF, acute-on-chronic liver failure; ACLF-JM, acute-on-chronic liver failure joint model; AUC, area under receiver-operating characteristic curve; MELD-Na, model for end-stage liver disease-sodium.